Table of contents

Hepatology

• Original article: MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway (17 August, 2015)

  Heng Wu, Raymond Ng, Xin Chen, Clifford J Steer, Guisheng Song
• Original article: Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort (7 September, 2016)

  Tania M Welzel, Jörg Petersen, Kerstin Herzer, Peter Ferenci, Michael Gschwantler, Heiner Wedemeyer, Thomas Berg, Ulrich Spengler, Ola Weiland, Marc van der Valk, Jürgen Rockstroh, Markus Peck-Radosavljevic, Yue Zhao, Maria Jesus Jimenez-Exposito, Stefan Zeuzem
• Original article:

  Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption

  (24 May, 2016)

  Nicolas Calo, Pierluigi Ramadori, Cyril Sobolewski, Yannick Romero, Christine Maeder, Margot Fournier, Pia Rantakari, Fu-Ping Zhang, Matti Poutanen, Jean-François Dufour, Bostjan Humar, Serge Nef, Michelangelo Foti
• Original article: Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression (3 September, 2015)

  Xavier Loyer, Valérie Paradis, Carole Hénique, Anne-Clémence Vion, Nathalie Colnot, Coralie L Guerin, Cécile Devue, Sissi On, Jérémy Scetbun, Mélissa Romain, Jean-Louis Paul, Marc E Rothenberg, Patrick Marcellin, François Durand, Pierre Bedossa, Carina Prip-Buus, Eric Baugé, Bart Staels, Chantal M Boulanger, Alain Tedgui, Pierre-Emmanuel Rautou